Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/FL/Pembroke Pines
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Pembroke Pines, FL

Studies commonly pay $75 to $4,500 per completed study

2,002 clinical trials are currently recruiting participants within 30 miles of Pembroke Pines. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

2,002studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Pembroke Pines right now

Top 25 of 2,002 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Multiple Myeloma Phase 3 Interventional 893 participants sought
Sylvester Comprehensive Cancer Center - Hollywood — Hollywood, Florida (11.7 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05020236)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Nicklaus Children's Hospital — Miami, Florida (18.8 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Advanced Solid Tumors Phase 1, Phase 2 Interventional 83 participants sought
Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida (20.1 mi) · Sponsor: Jiangsu HengRui Medicine Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT05277168)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
University of Miami - Miller School of Medicine — Coral Gables, Florida (20.6 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Healthy Volunteers, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Phase 1, Phase 2 Interventional 172 participants sought
Genoma Research Group, Inc — Miami, Florida (18.8 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05648214)

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma Phase 1 Interventional 168 participants sought
BRCR Global — Tamarac, Florida (14.9 mi) · Sponsor: OncoNano Medicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06022029)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Memorial Regional Hospital/Joe DiMaggio Children's Hospital — Hollywood, Florida (11.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial

Mild Cognitive Impairment (MCI), Cognitive Training Phase 2 Interventional 240 participants sought
University of Miami Miller School of Medicine — Miami, Florida (18.8 mi) · Sponsor: Columbia University
See eligibility & contact on ClinicalTrials.gov (NCT06601933)

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Chronic Graft-versus-host Disease (cGVHD) Phase 2 Interventional 120 participants sought
Univ of Miami - Sylvester Comprehensive Cancer Center — Miami, Florida (18.8 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06660355)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Mount Sinai Braman Comprehensive Cancer Center ( Site 0140) — Miami Beach, Florida (20.1 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
University of Miami/Sylvester Cancer Institute - Plantation — Plantation, Florida (10.7 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications Phase 3 Interventional 115 participants sought
University of Miami/Jackson Memorial Hospital (Adults only) — Miami, Florida (18.8 mi) · Sponsor: Pierre Fabre Medicament
See eligibility & contact on ClinicalTrials.gov (NCT03394365)

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Phase 2 Interventional 38 participants sought
Nicklaus Children's Hospital — Miami, Florida (18.8 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05286788)

Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation

Cochlear Implants, Cochlear Implantation N/A Interventional 54 participants sought
University of Miami — Miami, Florida (18.8 mi) · Sponsor: Restorear Devices LLC
See eligibility & contact on ClinicalTrials.gov (NCT06375278)

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

Migraine Phase 2 Interventional 488 participants sought
Flourish Research - Miami, LLC dba Flourish Research — Miami, Florida (18.8 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06602479)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Miami, Florida (18.8 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Miami Beach, Florida (20.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Tamarac, Florida (14.9 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Non-segmental Vitiligo Phase 2 Interventional 45 participants sought
Skin Care Research, LLC — Hollywood, Florida (11.7 mi) · Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07223229)

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Chin Augmentation N/A Interventional 100 participants sought
Galderma Investigational Site # 7030 — Coral Gables, Florida (20.6 mi) · Sponsor: Galderma R&D
See eligibility & contact on ClinicalTrials.gov (NCT07566286)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Ft Lauderdale Eye Institute — Plantation, Florida (10.7 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)
Actively enrolling

Studies you may be able to join near Pembroke Pines

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Pembroke Pines

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

American Research Centers of Florida

★ 5.0
1 SW 129th Ave, Pembroke Pines, FL 33027
(954) 237-3799

FXM Clinical Research Miramar, LLC

★ 5.0
14601 SW 29th St #208, Miramar, FL 33027
(954) 430-1097
"Excelente atención todas las personas muy amables"
— Marcela, 5★

South Broward Research

3000 SW 148th Ave #112, Miramar, FL 33027
(954) 433-5867

CenExel Hollywood FL

★ 4.1
7261 Sheridan St Suite 210, Hollywood, FL 33024
(954) 990-7649
"Very, very dissatisfied with the customer service"
— kalvin McGruder, 1★

INTEGRITY CLINICAL RESEARCH CENTER INC

★ 5.0
7590 NW 186th St Ste 209, Hialeah, FL 33015
(786) 953-6263
"An excellent doctor, with wonderful care from the entire team."
— Carmen De Paz, 5★

Eminat Research Group

★ 5.0
14601 SW 29th St Suite 108, Miramar, FL 33027
(954) 374-7547
"Good service; fast, friendly treatment, I have a good impression of the place every time I've been here"
— Rogelio, 5★

Best Choice Medical and Research Service

★ 5.0
1900 N University Dr, Pembroke Pines, FL 33024
(786) 658-3867

Pinnacle Medical Research LLC

★ 5.0
7777 Davie Road Extension Ste 202a, Hollywood, FL 33024
(954) 534-7674
"I had a great experience! The team is very organized and professional! They explain every step of the process clearly! Would definitely recommend!"
— Michaella Talone, 5★

Wellness Clinical Research

★ 5.0
8040 NW 155th St Second Floor, Miami Lakes, FL 33016
(786) 483-7856
"En este lugar te sientes como en familia son los mejores los recomiendo 100% son un colectivo muy profesional excelente trabajo."
— Yeniel León, 5★

Clinical trials in Pembroke Pines: what's recruiting

The Pembroke Pines area currently has 2,002 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Pembroke Pines, the most active research areas are:

  • Cancer & Oncology11 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Pembroke Pines, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Pembroke Pines

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Pembroke Pines participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Pembroke Pines?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Pembroke Pines?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Pembroke Pines?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Pembroke Pines.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Pembroke Pines typically complete one or two studies per year.

Paid clinical trials near Pembroke Pines

Other metros within reach

Hialeah, FL1,956 Hollywood, FL2,002 Fort Lauderdale, FL2,008 Miami, FL1,931 Port St. Lucie, FL103 Bonita Springs, FL300 Cape Coral, FL242 Palm Bay, FL71

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Pembroke Pines Severe Chronic Pruritus in Pembroke Pines Chronic Kidney Disease (HealthMatch) in Pembroke Pines Bladder Issues Due To Spinal Cord Injury in Pembroke Pines All conditions

More of FL

Fort Lauderdale2,008 Hollywood2,002 Hialeah1,956 Miami1,931 St. Petersburg1,354 Tampa1,335 Deltona966 Orlando950 Kissimmee934 Jacksonville924 Gainesville532

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts